Showing results (251-260 of 385) with videos related to

Sort By:
Pageof 39
JAMA Network Open|August 27, 2024
5-α Reductase Inhibitors and Prostate Cancer MortalityRobert J Hamilton, Julian Chavarriaga, Najia Khurram, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
North American study and meta-analysis evaluating performance of Bladder EpiCheck®, a FDA cleared test, in non-muscle invasive bladder cancer recurrenceNeil Fleshner, Herbert Barton Grossman, Ryan Berglund, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2014
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancerYann Neuzillet, Bas W G van Rhijn, Nadia L Prigoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancerShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Clinical Genitourinary Cancer|April 13, 2020
A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate CancerAmanda E Hird, Diana E Magee, Bimal Bhindi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 19, 2010
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary baseJoseph L Chin, John Srigley, Linda A Mayhew, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2008
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studiesStephane Supiot, Shubber Shubbar, Neil Fleshner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?Richard Walker, Uri Lindner, Alyssa Louis, et al.
Urologic Oncology|June 17, 2021
Characterization and management of NMIBC recurrences after TMT: a matched cohort analysisKhaled Ajib, Mohamad Baker Berjaoui, JaimeOmar Herrera-Caceres, et al.
Pageof 39